-
10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0206_002
Dataset
EGAD00001011235
-
10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0014_001
Dataset
EGAD00001011251
-
10x Single Cell Gene Expression Library SCRNA10X_SA_CHIP0015_001
Dataset
EGAD00001011252
-
RNA-seq data from the tumor samples of head and neck cancer patients
Dataset
EGAD00001011279
-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Dataset
EGAD00001011297
-
Genome and transcriptome sequence data from a angiosarcoma tumor patient
Dataset
EGAD00001015290
-
Machine Learning Guided Signal Enrichment for Plasma Tumor-burden Monitoring Dataset
Dataset
EGAD00001011352
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 9 part 1)
Dataset
EGAD00001011353
-
neoALTTO
Dataset
EGAD00001011354
-
An MTOR mutation hitchhikes through renal embryogenesis, driving multifocal, multiphenotypic tumours - RNA
Dataset
EGAD00001011646
-
RNA-sequencing of Human Thyroid cancer cell lines
Dataset
EGAD00001011677
-
Characterising the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER
Dataset
EGAD00001015411
-
Somatic mutant selection is altered by prior NOTCH1 mutation in ageing esophageal epithelium
Dataset
EGAD00001015258
-
The long term effects of chemotherapy on normal blood - Nanoseq dataset
Dataset
EGAD00001015340
-
Sequencing data for "Replication timing alterations are associated with mutation acquisition during tumour evolution in breast and lung cancer"
Dataset
EGAD00001015363
-
To profile the landscape of sebaceous tumours_WES
Dataset
EGAD00001015367
-
DNA WGS Short Read Sequence (Illumina NovaSeq) for manuscript titled: "Performance of Somatic Structural Variant Calling in Lung Cancer using Oxford Nanopore Sequencing Technology"
Dataset
EGAD00001015399
-
DNA WGS Long Read Sequence (PromethION) for manuscript titled: "Performance of Somatic Structural Variant Calling in Lung Cancer using Oxford Nanopore Sequencing Technology"
Dataset
EGAD00001015400
-
Somatic mutation in edited cholangiocyte organoids
Dataset
EGAD00001015456
-
The earliest stages of neoplastic transformation in Familial Adenomatous Polyposis
Dataset
EGAD00001015471
-
Geographic and age-related variations in mutational processes in colorectal cancer - sequence data (Mutographs)
Dataset
EGAD00001015485
-
Geographic and age-related variations in mutational processes in colorectal cancer - filtered vcf files (Mutographs)
Dataset
EGAD00001015486
-
Geographic and age-related variations in mutational processes in colorectal cancer - copy number variants (Mutographs)
Dataset
EGAD00001015487
-
HCA Organoids | Colon - Cancer, Multiome Sequencing Data
Dataset
EGAD00001015504
-
GBM-Space: Spatial Transcriptomic Profiling of Glioblastoma (10x Genomics - Visium)
Dataset
EGAD00001015527
-
HCA Organoids | Colon - Cancer, Nanopore Sequencing Data
Dataset
EGAD00001015536
-
Genome and transcriptome sequence data from a malignant peripheral nerve sheath tumor patient
Dataset
EGAD00001015583
-
RNA-seq dataset of Characterization of UV DNA damage in B-cell precursor acute lymphoblastic leukemia
Dataset
EGAD00001015598
-
scWGS dataset of Characterization of UV DNA damage in B-cell precursor acute lymphoblastic leukemia
Dataset
EGAD00001015601
-
Single-Cell Data from "Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer"
Dataset
EGAD00001015632
-
WXS dataset of Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience
Dataset
EGAD00001015638
-
Colorectal Microenvironment Spatial Mapping Dataset
Dataset
EGAD00001015675
-
PHRT study of longitudinal sampling in ovarian cancer
Study
EGAS50000001424
-
Single cell RNA sequencing reveals induced bifurcated differentiation after RUNX1::RUNX1T1 depletion in patient-derived leukemic blasts
Study
EGAS00001008050
-
METABRIC
Study
EGAS00000000083
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
ecDNA copy number heterogeneity
Study
EGAS50000000509
-
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in HGSOC
Study
EGAS00001006807
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Study
EGAS00001002699
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Sensitive and Frequent Identification of High Avidity Neo-epitope Specific CD8 + T-cells in Immunotherapy-naïve Ovarian Cancer
Study
EGAS00001002803
-
“Castration-persistence” is a distinct state of tolerance to androgen receptor targeting therapies in prostate cancer
Study
EGAS00001003172
-
FOXM1 is a biomarker of resistance to PI3Kα inhibition in ER+ breast cancer that is detectable using metabolic imaging (RNA-seq data)
Study
EGAS00001004452
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in breast tumors from breast cancer patients.
Study
EGAS00001004671
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Single-cell profiling of neoantigen-specific T cells in lung cancers treated with neoadjuvant PD-1 blockade
Study
EGAS00001005343
-
RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors
Study
EGAS00001005588
-
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers
Study
EGAS00001005676
-
Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer
Study
EGAS00001005736
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Study
EGAS00001006251
-
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.
Study
EGAS00001006652
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (H021)
Study
EGAS00001006706
-
Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin
Study
EGAS00001006879
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Study
EGAS00001007242
-
Clinical outcomes and immune correlates of response to nivolumab plus chemoradiotherapy in women with locally-advanced cervical cancer – NiCOL study
Study
EGAS00001007297
-
Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors
Study
EGAS00001007327
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
Study
EGAS00001007590
-
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Study
EGAS00001007877
-
Genome-wide association study identifies common variants associated with breast cancer in South African Black women
Study
EGAS00001008032
-
Cancer of Low survival and UnMet Need – Pathologist Initiated
Study
EGAS00001008112